Asaf Vivante

5.5k citations
62 papers · 2.0k indexed · h-index 22
Topics
Renal and related cancers (16 papers)Renal Diseases and Glomerulopathies (9 papers)Pediatric Urology and Nephrology Studies (9 papers)

In The Last Decade

Asaf Vivante

60 papers receiving 2.0k citations

Peers

Asaf Vivante
Comparison fields: 5 of 115
  • Molecular Biology 950
  • Nephrology 641
  • Pediatrics, Perinatology and Child Health 576
  • Genetics 327
  • Pulmonary and Respiratory Medicine 326
Replace Mark W. Burns with:
Mark W. Burns United States
Françoise Müller France
Pierre Cochat France
Il Soo Ha South Korea
Hee Gyung Kang South Korea
Oğuz Söylemezoğlu Türkiye
Ekaterini Siomou Greece
Kevin Meyers United States
İlmay Bilge Türkiye
Matthew N. Simmons United States
Asaf Vivante relative to Mark W. Burns United States Mark W. Burns's profile →
Citations per field
00.5×10×15×21.8×
Mark W. Burns · 1×
Citations per year

Countries citing papers authored by Asaf Vivante

Since Specialization
Citations

This map shows the geographic impact of Asaf Vivante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asaf Vivante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asaf Vivante more than expected).

Fields of papers citing papers by Asaf Vivante

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asaf Vivante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asaf Vivante. The network helps show where Asaf Vivante may publish in the future.

Co-authorship network of co-authors of Asaf Vivante

This figure shows the co-authorship network connecting the top 25 collaborators of Asaf Vivante. A scholar is included among the top collaborators of Asaf Vivante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asaf Vivante. Asaf Vivante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 3
3 16
4 2
5 28
6 6
7 9
8 1
9 13
10 9
11 14
12 18
13 27
14 5
15 21
16 67
17 154
18 8
19 140
20 25

About Asaf Vivante

Asaf Vivante is a scholar working on Nephrology, Pediatrics, Perinatology and Child Health and Urology, having authored 62 papers that have together received 2.0k indexed citations. Recurring topics across this work include Renal and related cancers (16 papers), Renal Diseases and Glomerulopathies (9 papers) and Pediatric Urology and Nephrology Studies (9 papers). The work is most often cited by research in Nephrology (641 citations), Urology (231 citations) and Pediatrics, Perinatology and Child Health (576 citations). Asaf Vivante has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Friedhelm Hildebrandt, Karl Skorecki, Dorit Tzur, Ronit Calderon‐Margalit, Adi Leiba, Eliezer Golan, Daw‐Yang Hwang, Stefan Kohl, Gabriel C. Dworschak and Amir Tirosh. Their work appears in journals such as New England Journal of Medicine, JAMA and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026